Relationship between PPARα mRNA expression and mitochondrial respiratory function and ultrastructure of the skeletal...

Area of Science:

• Pulmonary Medicine
• Skeletal Muscle Physiology
• Molecular Biology

Background:

• Peripheral muscle dysfunction is a significant complication in chronic obstructive pulmonary disease (COPD).
• Understanding the molecular mechanisms underlying muscle dysfunction in COPD is crucial for developing targeted therapies.
• Peroxisome proliferator-activated receptor α (PPARα) plays a role in muscle metabolism and function.

Purpose of the Study:

• To investigate the relationship between PPARα mRNA expression and mitochondrial respiratory function and ultrastructure in the vastus lateralis muscle of COPD patients.
• To compare these parameters between COPD patients with low body mass index (BMIL) and normal body mass index (BMIN), and healthy controls.

Main Methods:

• Vastus lateralis muscle biopsies from 14 COPD patients and 6 controls.
• Real-time PCR to quantify PPARα mRNA levels.
• Clark oxygen electrode for mitochondrial respiratory function assessment.
• Transmission electron microscopy for mitochondrial morphology and Z-line analysis.

Main Results:

• PPARα mRNA expression was significantly lower in BMIL COPD patients compared to BMIN COPD patients and controls.
• Mitochondrial respiratory function was impaired in COPD patients, particularly in the BMIL group.
• Mitochondrial number and fractional area were reduced in BMIL patients, while Z-lines narrowed. PPARα mRNA expression correlated positively with mitochondrial respiratory function and volume density.

Conclusions:

• Reduced PPARα mRNA expression is associated with impaired mitochondrial respiratory function and reduced mitochondrial volume density in COPD patients.
• These molecular and cellular changes in skeletal muscle may contribute to peripheral muscle dysfunction observed in COPD, especially in patients with low body mass index.